Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 4, 2006Journal of the American Society of Nephrology

Ace2

View Full Paper
Ask AI
Bookmark
Share

Design

Editorial

Authors

JIJulie R. IngelfingerWesleyan University

Discussion

Loading...

Member takes

Implication

Supports ACE2's protective role in diabetic nephropathy; leaves open whether ACE2 modulation alters clinical outcomes.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Julie R. Ingelfinger (2006) studied this question.

synapsesocial.com/papers/6a82a937e41271e79b8d5e33https://doi.org/10.1681/asn.2006090986
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Characterization of Renal Angiotensin-Converting Enzyme 2 in Diabetic Nephropathy2003 · 356 citations
  2. 2ACE and ACE2 Activity in Diabetic Mice2006 · 339 citations
  3. 3Glomerular Localization and Expression of Angiotensin-Converting Enzyme 2 and Angiotensin-Converting Enzyme2006 · 494 citations
  4. 4Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations1993 · 310 citations
  5. 5Tissue Gene Expression of Renin-Angiotensin System in Human Type 2 Diabetic Nephropathy2006 · 72 citations